Literature DB >> 10478707

Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity.

P W Kaplan1.   

Abstract

Nonconvulsive status epilepticus (NCSE) is characterized by behavioral or cognitive change from baseline for at least 30 minutes with EEG evidence of seizures. Categorized into complex partial status epilepticus (with lateralized seizures), and generalized nonconvulsive status epilepticus (bilateral diffuse synchronous seizures), there is debate regarding the diagnosis and morbidity of NCSE. Because EEG is needed for diagnosis, only a high index of suspicion leads to a request for the study, whereas EEG is often unavailable after hours or on weekends. Furthermore, the cognitive changes during NCSE are often incorrectly ascribed to a postictal state, intoxication, psychogenic or psychotic states, and mental retardation. Regarding categorization, present classifications address EEG features but fail to distinguish among depths of coma. Deeply comatose patients (with coma etiologies that themselves carry poor prognoses) are mixed with lightly obtunded patients with no morbidity, confusing the prognosis. Thus, a classification that subsumes depth of coma, and possibly etiology, is sorely warranted. Regarding treatment, comatose NCSE patients treated with benzodiazepines may worsen, whereas generalized nonconvulsive status epilepticus patients may suffer iatrogenically from aggressive treatment (hypotension and respiratory depression) necessitating balancing the potential neurologic morbidity of NCSE against the possible morbidity of IV antiepileptic drugs. A high index of suspicion is needed to initiate EEG studies. Better stratification of level of consciousness will be needed to distinguish among morbidity due to underlying conditions, treatment, and the effects of status epilepticus, proper.

Entities:  

Mesh:

Year:  1999        PMID: 10478707     DOI: 10.1097/00004691-199907000-00006

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  37 in total

1.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists.

Authors:  M Holtkamp; F Masuhr; L Harms; K M Einhäupl; H Meierkord; K Buchheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

2.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures.

Authors:  Aatif M Husain; Jong W Lee; Bradley J Kolls; Lawrence J Hirsch; Jonathan J Halford; Puneet K Gupta; Yafa Minazad; Jennifer M Jones; Suzette M LaRoche; Susan T Herman; Christa B Swisher; Saurabh R Sinha; Adriana Palade; Keith E Dombrowski; William B Gallentine; Cecil D Hahn; Elizabeth E Gerard; Manjushri Bhapkar; Yuliya Lokhnygina; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

3.  Cyclic hyperammoniemic encephalopathy and epileptiform triphasic waves: problems in differential diagnosis with nonconvulsive status epilepticus.

Authors:  Alberto Primavera; Daniela Audenino
Journal:  Neurol Sci       Date:  2009-02-24       Impact factor: 3.307

4.  Status epilepticus.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

5.  Cefixime-induced nonconvulsive status epilepticus.

Authors:  F Anzellotti; L Ricciardi; D Monaco; F Ciccocioppo; I Borrelli; H Zhuzhuni; M Onofrj
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

Review 6.  Status epilepticus: an update.

Authors:  Panayiotis N Varelas; Marianna V Spanaki; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

Review 7.  Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician.

Authors:  Mario A Cristancho; Yesne Alici; John G Augoustides; John P O'Reardon
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

8.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 9.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

10.  Nonconvulsive status epilepticus manifesting as bradyphrenia: a case report.

Authors:  Martijn Weisfelt; Dick van den Wijngaard
Journal:  Cases J       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.